共 131 条
- [1] Siegel RL(2017)Cancer statistics, 2017 CA Cancer J Clin 67 7-30
- [2] Miller KD(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
- [3] Jemal A(2016)Non-small cell lung cancer: current treatment and future advances Transl Lung Cancer Res 5 288-300
- [4] Bray F(2008)Lung cancer N Engl J Med 359 1367-1380
- [5] Ferlay J(2017)Targeting lung cancer stem cells: research and clinical impacts Front Oncol 7 80-114
- [6] Soerjomataram I(2016)Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake? Transl Lung Cancer Res 5 110-642
- [7] Siegel RL(2016)FDA approval summary: nivolumab for the treatment of metastatic non-small cell lung cancer with progression on or after platinum-based chemotherapy Oncologist 21 634-308
- [8] Torre LA(2016)Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study Lancet Oncol 17 299-119
- [9] Jemal A(2016)Overall survival in non-small cell lung cancer-what is clinically meaningful? Transl Lung Cancer Res 5 115-355
- [10] Zappa C(2013)Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite? J Pathol 230 350-1214